Classic Case of Unicentric Mixed-Type Castleman's Disease

被引：5

作者：

Nagubandi, Ravi ^{[1
]}

Wang, Yanhua ^{[1
]}

Dutcher, Janice P. ^{[1
]}

Rao, Prakashchandra M. ^{[1
]}

机构：

[1] Montefiore Med Ctr, North Div, Bronx, NY 10467 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 36期

关键词：

MANAGEMENT;

D O I：

10.1200/JCO.2012.45.9941

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E452 / E455

页数：4

共 9 条

[1]

Bowne WB, 1999, CANCER, V85, P706, DOI 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO

[2]

2-7

[3] The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J].

Casper, C .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (01) :3-17

[4] The clinical spectrum of Castleman's disease [J].

Dispenzieri, Angela ;

Armitage, James O. ;

Loe, Matt J. ;

Geyer, Susan M. ;

Allred, Jake ;

Camoriano, John K. ;

Menke, David M. ;

Weisenburger, Dennis D. ;

Ristow, Kay ;

Dogan, Ahmet ;

Habermann, Thomas M. .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (11) :997-1002

[5] Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics [J].

El-Osta, Hazem E. ;

Kurzrock, Razelle .

ONCOLOGIST, 2011, 16 (04) :497-511

[6]

KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO

[7]

2-#

[8] Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide [J].

Lee, FC ;

Merchant, SH .

AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (01) :48-53

[9] Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease [J].

Nishimoto, N ;

Kanakura, Y ;

Aozasa, K ;

Johkoh, T ;

Nakamura, M ;

Nakano, S ;

Nakano, N ;

Ikeda, Y ;

Sasaki, T ;

Nishioka, K ;

Hara, M ;

Taguchi, H ;

Kimura, Y ;

Kato, Y ;

Asaoku, H ;

Kumagai, S ;

Kodama, F ;

Nakahara, H ;

Hagihara, K ;

Yoshizaki, K ;

Kishimoto, T .

BLOOD, 2005, 106 (08) :2627-2632

← 1 →